SCHEMBL8670032

SCHEMBL8670032

NCCC(N)(CCN1C(=O)c2cccc3cccc(c23)C1=O)CCN1C(=O)c2cccc3cccc(c23)C1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HEXA P06865 6/20 0.70
▸ HEXB P07686 6/20 0.70
▸ OGA O60502 1/20 0.59
▸ LCK P06239 1/20 0.56
▸ SIRT1 Q96EB6 3/20 0.55
▸ KDM4E B2RXH2 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ GAA P10253 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ CYP1B1 Q16678 1/20 0.51
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ NR1I2 O75469 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ AHR P35869 1/20 0.50
▸ RAD52 P43351 1/20 0.50
▸ RCE1 Q9Y256 1/20 0.50
▸ CA12 O43570 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalimidopropylamine SCHEMBL12502105 0.83 HEXA (1.00) HEXAHEXBOGALCKSIRT1
SCHEMBL626424 0.82 HEXA (1.00) HEXAHEXBOGALCKSIRT1
SCHEMBL8984898 0.81 KDM4E (0.58) HEXAHEXBOGAKDM4EALDH1A1
Hydrochloric Acid SCHEMBL28259369 0.81 HEXA (0.96) HEXAHEXBOGALCKSIRT1
SCHEMBL5094701 0.78 HEXA (1.00) HEXAHEXBOGALCKSIRT1
SCHEMBL6601488 0.77 HEXA (0.97) HEXAHEXBOGALCKSIRT1
SCHEMBL9092483 0.77 HEXA (0.82) HEXAHEXBOGALCKSIRT1
Hydrochloric Acid SCHEMBL5748029 0.77 HEXA (0.82) HEXAHEXBOGALCKSIRT1
SCHEMBL10396736 0.76 HEXA (0.69) HEXAHEXBOGALCKSIRT1
SCHEMBL9626265 0.76 HEXA (0.83) HEXAHEXBOGASIRT1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789418-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1998-08-04 — — US disclosed
Send feedback